MENU

DMAC DiaMedica Therapeutics Forecast, Technical & Fundamental Analysis

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology
DMAC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
DMAC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

DMAC is expected to report earnings to rise 5.26% to -20 cents per share on November 11

DiaMedica Therapeutics DMAC Stock Earnings Reports
Q3'26
Est.
$-0.20
Q2'26
Est.
$-0.19
Q1'26
Est.
$-0.19
Q4'25
Est.
$-0.17
Q3'25
Est.
$-0.17
The last earnings report on August 10 showed earnings per share of -18 cents, meeting the estimate of -18 cents. With 76.34K shares outstanding, the current market capitalization sits at 467.54M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCCC3.160.27
+9.34%
C4 Therapeutics
PLRX0.910.01
+1.52%
Pliant Therapeutics
SAM184.202.38
+1.31%
Boston Beer Company
KTH28.53N/A
N/A
Structured Products CorTS PECO Energy Cap Trust III
DRS33.94-1.24
-3.52%
Leonardo DRS

DMAC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, DMAC has been loosely correlated with VIR. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if DMAC jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DMAC
1D Price
Change %
DMAC100%
+10.17%
VIR - DMAC
45%
Loosely correlated
+5.19%
EDIT - DMAC
45%
Loosely correlated
+6.61%
TSHA - DMAC
44%
Loosely correlated
+4.31%
ANNX - DMAC
42%
Loosely correlated
-4.49%
SLDB - DMAC
41%
Loosely correlated
+8.11%
More
A.I. Advisor
published General Information

General Information

a developer of novel therapeutic compounds for diabetes and other diseases

Industry Biotechnology

Industry
Biotechnology
Address
301 Carlson Parkway
Phone
+1 763 496-5454
Employees
35
Web
https://www.diamedica.com
DiaMedica Therapeutics (DMAC) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com